Artículos por temáticas

Cerebral Small Vessel Disease: Early-Life Antecedents and Long-Term Implications for the Brain, Aging, Stroke, and Dementia

Backhouse EV, Boardman JP, Wardlaw JM.

Hypertension. 2024 Jan;81(1):54-74. doi: 10.1161/HYPERTENSIONAHA.122.19940. Epub 2023 Sep 21.

Is headache a risk factor for dementia? A systematic review and meta-analysis

Cermelli A, Roveta F, Giorgis L, Boschi S, Grassini A, Ferrandes F, Lombardo C, Marcinnò A, Rubino E, Rainero I.

Neurol Sci. 2024 Mar;45(3):1017-1030. doi: 10.1007/s10072-023-07069-0. Epub 2023 Sep 18.

Atypical TDP-43 proteinopathy clinically presenting with progressive nonfluent aphasia: A case report

Suzuki Y, Adachi T, Yoshida K, Taneda K, Sakuwa M, Hasegawa M, Hanajima R.

Neuropathology. 2024 Apr;44(2):154-160. doi: 10.1111/neup.12942. Epub 2023 Sep 17.

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022

Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M,

Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

How Do Modifiable Risk Factors Affect Alzheimer's Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?

Ourry V, Binette AP, St-Onge F, Strikwerda-Brown C, Chagnot A, Poirier J, Breitner J, Arenaza-Urquijo EM, Rabin JS, Buckley R, Gonneaud J, Marchant NL, Villeneuve S.

Biol Psychiatry. 2024 Jun 1;95(11):1006-1019. doi: 10.1016/j.biopsych.2023.09.003. Epub 2023 Sep 7.

Effects of Sport Stacking on Cognition in Patients With Mild Alzheimer's Disease and MCI: Preliminary Findings of Randomized Controlled Trial

Yang Z, Yang J, Yu DSF, Liu D, Ding F.

J Geriatr Psychiatry Neurol. 2024 Jan;37(1):24-38. doi: 10.1177/08919887231195227. Epub 2023 Sep 5.

Practical Application of a Battery of Brief Tools to Evaluate Geriatric Medical Inpatients for the Three Ds

Alviz Núñez M, Villa García MM, Gonzalez MC, Urrea MB, Velásquez-Tirado JD, Ocampo MV, Trzepacz PT, Franco JG.

J Neuropsychiatry Clin Neurosci. 2024 Winter;36(1):63-69. doi: 10.1176/appi.neuropsych.20230029. Epub 2023 Sep 5.

Blood-Brain Barrier Disruption and Perivascular Spaces in Small Vessel Disease and Neurodegenerative Diseases: A Review on MRI Methods and Insights

Voorter PHM, van Dinther M, Jansen WJ, Postma AA, Staals J, Jansen JFA, van Oostenbrugge RJ, van der Thiel MM, Backes WH.

J Magn Reson Imaging. 2024 Feb;59(2):397-411. doi: 10.1002/jmri.28989. Epub 2023 Sep 1.

Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD

Wang X, Sundermann EE, Buckley RF, Banks SJ; A4 Study Team.

Alzheimers Dement. 2024 Jan;20(1):25-33. doi: 10.1002/alz.13432. Epub 2023 Aug 28.

Update on the role of T cells in cognitive impairment

Ruiz-Fernández I, Sánchez-Díaz R, Ortega-Sollero E, Martín P.

Br J Pharmacol. 2024 Mar;181(6):799-815. doi: 10.1111/bph.16214. Epub 2023 Sep 2.

Language Impairment in Vascular Dementia: A Clinical Review

Macoir J.

J Geriatr Psychiatry Neurol. 2024 Mar;37(2):87-95. doi: 10.1177/08919887231195225. Epub 2023 Aug 8.

Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease

Wu JJ, Zhang L, Liu D, Xia J, Yang Y, Tang F, Chen L, Ao H, Peng C.

J Ethnopharmacol. 2024 Jan 10;318(Pt B):116955. doi: 10.1016/j.jep.2023.116955. Epub 2023 Aug 1.

Development of mobile compatible software for cognitive-communication disorder in individuals with Alzheimer's disease

Parlak MM, Köse A, Güç M, Munis ÖB.

Int J Lang Commun Disord. 2024 Jan-Feb;59(1):234-254. doi: 10.1111/1460-6984.12941. Epub 2023 Aug 1.

Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss

Carlos AF, Koga S, Graff-Radford NR, Baker MC, Rademakers R, Ross OA, Dickson DW, Josephs KA.

Neuropathology. 2024 Apr;44(2):115-125. doi: 10.1111/neup.12938. Epub 2023 Jul 31.